Cholesterol-Slashing Drug Does Not Impair Brain
A new cholesterol-slashing drug that has shown promise for high-risk patients does not impair brain function, according to a study out Saturday. Previous research had raised the possibility that evolocumab, sold under the brand name Repatha by Amgen, may have a damaging effect on memory and cognitive function. Evolocumab is part of a new class … Read more